Dietze Eric, Jones Veronica, Seewaldt Victoria
City of Hope Comprehensive Cancer Center and Beckman Institute, Duarte, CA.
Curr Breast Cancer Rep. 2020 Jun;12(2):118-124. doi: 10.1007/s12609-020-00358-z. Epub 2020 Feb 26.
Breast Self-Examination (BSE) remains controversial despite the 2009 United States Preventive Service Task Force (USPSTF) recommendation against teaching of BSE. The USPSTF recommendations were based on results from the Shanghai Study, high-quality randomized trial of BSE in 266,064 Chinese factory workers from 1989-1991; women instructed in BSE did not have a significant difference in mortality versus uninstructed controls. Regardless of the outcome of the Shanghai Study, the practice of BSE in the United States (U.S.) over the past 25 years has been associated with a marked reduction in the size of breast cancer identified by women.
In the Shanghai study, BSE was tested in China from 1989-1991. During this time period, Chinese breast cancer screening and treatment was not consistent with standard-of-care in U.S. and Europe. Breast cancer was a rare illness in China in the 1980's. Treatment was not standardized; there was no breast imaging or margin assessment of the tumor. Tumor markers (e.g. estrogen receptor, progesterone receptor) were not reported. The Shanghai Study did not report in detail on the anti-cancer agents provided to women who enrolled in the trial.
BSE needs to be rigorously re-evaluated under current standard of care.
尽管美国预防服务工作组(USPSTF)在2009年建议不教授乳房自我检查(BSE),但BSE仍存在争议。USPSTF的建议基于上海研究的结果,该研究是1989年至1991年对266,064名中国工厂女工进行的BSE高质量随机试验;接受BSE指导的女性与未接受指导的对照组相比,死亡率没有显著差异。无论上海研究的结果如何,过去25年美国女性进行BSE的做法与她们发现的乳腺癌规模显著减少有关。
在上海研究中,1989年至1991年在中国对BSE进行了测试。在此期间,中国的乳腺癌筛查和治疗与美国和欧洲的医疗标准不一致。20世纪80年代,乳腺癌在中国是一种罕见疾病。治疗不规范;没有对肿瘤进行乳房成像或切缘评估。未报告肿瘤标志物(如雌激素受体、孕激素受体)。上海研究没有详细报告为参加试验的女性提供的抗癌药物。
需要根据当前的医疗标准对BSE进行严格重新评估。